Can Nasonex (mometasone furoate) nasal spray be used to treat a child's common cold?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Nasonex Should Not Be Used to Treat a Child's Common Cold

Nasonex (mometasone furoate) is not indicated for the common cold and should not be used for this purpose in children. The medication is FDA-approved specifically for allergic rhinitis (seasonal and perennial) and nasal polyps—not for viral upper respiratory infections 1, 2.

Why Nasonex Is Not Appropriate for Colds

The Evidence Is Clear

The 2008 rhinitis guidelines explicitly state that "the efficacy of cold and cough medications for symptomatic treatment of upper respiratory tract infections has not been established for children younger than 6 years" 3. This applies to intranasal corticosteroids when used for viral infections rather than their approved indication of allergic rhinitis.

Mechanism Mismatch

  • Intranasal corticosteroids work by reducing allergic inflammation in the nasal mucosa 3
  • Common colds are viral infections that resolve spontaneously, typically within 10 days
  • The inflammatory process in viral rhinitis differs fundamentally from allergic inflammation
  • No evidence supports intranasal steroids improving cold symptoms or duration in children

What Nasonex IS Approved For

According to FDA labeling and clinical guidelines 1, 2:

For children ages 2-11 years:

  • Allergic rhinitis (seasonal and perennial)
  • Dosing: 1 spray per nostril once daily
  • Common side effects: headache, viral infection, pharyngitis, epistaxis, cough

For children ages 12+ years:

  • Allergic rhinitis
  • Dosing: 2 sprays per nostril once daily

Critical Distinction: Cold vs. Allergic Rhinitis

Signs of a Common Cold (Viral):

  • Clear to cloudy nasal discharge that improves by day 10
  • Fever for 1-2 days
  • Self-limited course
  • No treatment with Nasonex indicated

Signs of Allergic Rhinitis (When Nasonex IS Appropriate):

  • Persistent symptoms beyond 10 days
  • Sneezing, itching, clear rhinorrhea
  • Seasonal pattern or known allergen exposure
  • Nasal congestion without fever
  • Intranasal corticosteroids are the most effective medication class 3

Important Safety Considerations

Growth Monitoring in Children

When intranasal corticosteroids ARE appropriately used for allergic rhinitis, children should use them for the shortest duration necessary 2. The FDA label specifically states: "The growth rate of some children may be slower while using this product. Children should use for the shortest amount of time necessary to achieve symptom relief. Talk to your child's doctor if your child needs to use the spray for longer than two months a year" 2.

What TO Use for Pediatric Colds

The guidelines recommend supportive care only for common colds in children 3:

  • Adequate hydration
  • Saline nasal irrigation (not just spray)
  • Symptom monitoring for complications
  • Avoid OTC cough and cold medications in children under 6 years due to lack of efficacy and safety concerns 3

Bottom Line

Do not use Nasonex for treating a child's common cold. It is not effective for viral upper respiratory infections, is not FDA-approved for this indication, and exposes the child to unnecessary medication and potential side effects without benefit. Reserve Nasonex for its proven indication: allergic rhinitis in children ages 2 years and older, where it demonstrates clear efficacy as the most effective medication class for controlling allergic symptoms 3.

References

Guideline

clinical practice guideline: allergic rhinitis.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2015

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.